TrialCancer2014

Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck.

Ron R Allison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.